Rafael Holdings Files 8-K: Material Agreement & Equity Sales

Ticker: RFL · Form: 8-K · Filed: May 6, 2025 · CIK: 1713863

Sentiment: neutral

Topics: material-agreement, equity-sale, financials

TL;DR

Rafael Holdings 8-K: Material agreement, equity sales, and financials filed May 6, 2025.

AI Summary

On May 6, 2025, Rafael Holdings, Inc. filed an 8-K report detailing a material definitive agreement, unregistered sales of equity securities, and financial statements. The filing pertains to the company's operations in the pharmaceutical preparations sector.

Why It Matters

This 8-K filing provides crucial updates on significant corporate actions and financial disclosures for Rafael Holdings, Inc., impacting investors and stakeholders.

Risk Assessment

Risk Level: medium — 8-K filings can indicate significant corporate events, including material agreements and equity sales, which may carry inherent risks for investors.

Key Numbers

Key Players & Entities

FAQ

What specific material definitive agreement was entered into by Rafael Holdings, Inc. on or before May 6, 2025?

The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.

What type of equity securities were sold in the unregistered sale reported on May 6, 2025?

The filing mentions 'Unregistered Sales of Equity Securities' but does not specify the type of securities sold in the provided text.

What are the key items included in the financial statements and exhibits filed with this 8-K?

The filing states that 'Financial Statements and Exhibits' are included, but the specific content of these statements and exhibits is not detailed in the provided text.

What is the principal executive office address for Rafael Holdings, Inc.?

The principal executive offices are located at 520 Broad Street, Newark, New Jersey 07102.

What is the SIC code for Rafael Holdings, Inc.?

The Standard Industrial Classification (SIC) code for Rafael Holdings, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 6, 2025 regarding Rafael Holdings, Inc. (RFL).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing